Nasal and bronchial inflammation after nasal allergen challenge: Assessment using noninvasive methods

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 5, 2012, Pages 351-356

  Serrano, C D ^a   Santiago, Antonio Valero ^b,c,d   Bartra, J ^b,c,d   Roca Ferrer, J ^d   Munoz Cano R ^b,c,d   Sanchez Lopez J ^b,c,d   Mullol, J ^b,c,d   Picado, C ^b,c,d  

^a FUNDACIÓN VALLE DEL LILI   (Colombia)

^b HOSPITAL CLÍNIC   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Nasal allergen challenge; Nasal and bronchial infl ammation; Noninvasive methods

Indexed keywords

8 ISOPROSTANE; EOSINOPHIL CATIONIC PROTEIN; EXHALED NITRIC OXIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; LEUKOTRIENE; NASAL NITRIC OXIDE; NITRIC OXIDE; TRYPTASE; UNCLASSIFIED DRUG;

ACOUSTIC RHINOMETRY; ADULT; ALLERGIC RHINITIS; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXHALED BREATH CONDENSATE; FEMALE; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; NASAL GEOMETRY; NASAL INFLAMMATION; NASAL LAVAGE; NASAL SYMPTOM SCORE; NON INVASIVE MEASUREMENT; NOSE PROVOCATION TEST; OXIDATIVE STRESS; POLLEN ALLERGY; RESPIRATORY TRACT PARAMETERS; SCORING SYSTEM; SPIROMETRY; VISUAL ANALOG SCALE;

ADULT; ALLERGENS; ASTHMA; BREATH TESTS; FEMALE; HUMANS; MALE; NITRIC OXIDE; RHINITIS, ALLERGIC, SEASONAL;

EID: 84864803820     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111:1171-83.
2. Taramarcaz P, Gibson PG. The effectiveness of intranasal corticosteroids in allergic rhinitis and asthma syndrome. Clin Exp Allergy. 2004;34:1883-9.
3. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic patients. Am J Respir Crit Care Med. 2000;161:2051-1.
4. Braunstahl GJ, Overbeek SE, Fokkens WJ, Kleinjan A, McEuen AR, Walls AF, Hoogsteden HC, Prins JB. Segmental bronchial provocation in allergic rhinitis patients affects mast cells and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med. 2001;164:726-7.
5. Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001;107:469-76.
6. Gratziou C, Rovina N, Makris M, Simoes DC, Papapetropoulos A, Roussos C. Breath markers of oxidative stress and airway inflammation in Seasonal Allergic Rhinitis. Int J Immunopathol Pharmacol. 2008;21:949-57.
7. Marcucci F, Passalacqua G, Canonica GW, Frati F, Salvatori S, Di cara G, Petrini I, Bernini M, Novembre E, Bernardini R, Incorvaia C, Sensi LG. Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposurerelated phenomenon. Respir Med. 2007;101:1600-8.
8. Pelikan Z. Asthmatic response induced by nasal challenge with allergen. Int Arch Allergy Immunol. 2009;148:330-8.
9. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D; World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63 (Suppl 86):8-160.
10. Uzzaman A, Metcalfe D, Komarow H. Acoustic rhinometry in the practice of allergy. Ann Allergy Asthma Immunol. 2006;97:745-52.
11. Hilberg O, Pedersen OF. Acoustic rhinometry: recommendations for technical specifications and standard operating procedures. Rhinol Suppl. 2000;16:3-17.
12. Dordal MT, Luch-Bernal M, Sánchez MC, Rondon C, Navarro A, Montoro J, Matheu V, Ibañez MD, Fernandez-Parra B, Dávila I, Conde J, Antón E, Colás C, Valero A (SEAIC rhinoconjunctivitis committee). Allergen-specific nasal provocation testing: review by the rhinoconjunctivitis committee of the Spanish Society of Allergy and Clinical Immunology. J Investig Allergol Clin Immunol. 2011;21:1-12.
13. ATS Workshop Proceedings: Exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Executive summary. Am J Respir Crit Care Med. 2006;173:811-3.
14. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide. Am J Respir Crit Care Med. 2005;171:912-30.
15. Belda J, Parameswaran K, Keith PK, Hargreave FE. Repeatability and validity of cell and fluid-phase measurements in nasal fluid: a comparison of two methods of nasal lavage. Clin Exp Allergy. 2001;31:1111-5.
16. Cap P, Maly M, Pehal F, Pelikan Z. Exhaled leukotrienes and bronchial responsiveness to methacholine in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2009;102:103-9.
17. Cáp P, Pehal F, Chládek J, Malý M. Analysis of exhaled leukotrienes in nonasthmatic adult patients with seasonal allergic rhinitis. Allergy. 2005;60:171-6.
18. Bergmann-Hug K, Wirth R, Henseler M, Helbling A, Pichler WJ, Schnyder B. Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide. Allergy. 2009;64:1629-34.
19. Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, Buhl R. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy. 2003;33:475-82.
20. Pedroletti C, Lundahl J, Alving K, Hedlin G. Exhaled nitric oxide in asthmatic children and adolescents after nasal allergen challenge. Pediatr Allergy Immunol. 2005;16:59-64.
21. Howarth PH, Persson CG, Meltzer EO, Jacobson MR, Durham SR, Silkoff PE. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol. 2005;115 (Suppl 1):S414-41.
22. Boot JD, de Kam ML, Mascelli MA, Miller B, Gerth van Wijk R, de Groot H, Cohen AF, Diamant Z. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy. 2007;62:378-84.
23. Serrano C, Valero A, Picado C. Nasal nitric oxide. Arch Bronconeumol. 2004;40:222-30.
24. Inal A, Kendirly SG, Yilmaz M, Altintas DU, Karakoc GB, Erdogan S. Indices of lower airway inflammation in children monosensitized to house dust mite after nasal allergen challenge. Allergy. 2008;63:1345-51.
25. Kowalska A, Puśćcińska E, Czerniawska J, Goljan-Geremek A, Czystowska M, Rozy A, Chorostowska-Wynimko J, Górecka D. Markers of fibrosis and inflammation in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) of patients with pulmonary sarcoidosis: a pilot study. Pneumonol Alergol Pol. 2010;78:356-62.
26. Lehtonen H, Oksa P, Lehtimäki L, Sepponen A, Nieminen R, Kankaanranta H, Saarelainen S, Järvenpää R, Uitti J, Moilanen E. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax. 2007;62:602-7.
27. Effros RM, Su J, Casaburi R, Shaker R, Biller J, Dunning M. Utility of exhaled breath condensates in chronic obstructive pulmonary disease: a critical review. Curr Opin Pulm Med. 2005;11:135-9.
28. Robroeks CM, Rosias PP, van Vliet D, Jöbsis Q, Yntema JB, Brackel HJ, Damoiseaux JG, den Hartog GM, Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer. 2009;63:164-8.
29. Robroeks CM, Rosias PP, van Vliet D, Jöbsis Q, Yntema JB, Brackel HJ, Damoiseaux JG, den Hartog GM, Wodzig WK, Dompeling E. Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children. Pediatr Allergy Immunol. 2008;19:652-9.